Corrona Partners with National MS Society on Registry to Assess Safety and Efficacy of Therapies

Friday, October 20, 2017

Corrona, LLC and the National Multiple Sclerosis Society will collaborate on the launch of the Corrona Multiple Sclerosis (MS) Registry to study the comparative safety and effectiveness of approved MS therapies. The observational registry will collect and analyze longitudinal outcomes associated with multiple sclerosis therapies via questionnaires, physician assessments, and patient-reported outcomes. The first patient has been enrolled, with initial recruitment goals to register approximately 5,000 people with MS.

Corrona's collaboration with the National MS Society builds upon its successful ongoing collaboration for its Psoriasis registry with dermatologists and the National Psoriasis Foundation.

To learn more about the Corrona Multiple Sclerosis Registry and how to participate, visit

Next Story


You must be logged in to leave a comment.